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Running Title: Biologics-based technologies for root coverage 
 
One Sentence Summary: This review highlights the current evidence on the use of 
biologics-based technologies for periodontal soft tissue wound repair 
 
Abstract 
This manuscript provides a state-of-the-art review on the efficacy of biologics in root 
coverage procedures, including enamel matrix derivative, platelet-derived growth factor, 
platelet concentrates, and fibroblast-growth factor-2. The mechanism of action and the 
rationale for using biologics in periodontal plastic surgery, as well as their anticipated 
benefits when compared to conventional approaches are discussed. Although the clinical 
significance is still under investigation, preclinical data and histological evidence 
demonstrate that biologic-based techniques are able to promote periodontal regeneration 
coupled with the provision of tooth root coverage.  
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Biologics-based Regenerative Technologies 
Gingival recession is defined as the apical migration of the gingival margin from the cemento-enamel 
junction with the concomitant exposure of the root surface in the oral cavity 1. This condition also 
involves the resorption of the facial alveolar bone and associated structures. Therefore, it’s not 
surprising that guided tissue regeneration (GTR) was one of the first approaches that was proposed 
for the treatment of gingival recessions 2-4. However, the use of GTR for root coverage purposes has 
had several limitations, including limited predictability in cases of shallow recession defects or cases 
of thin gingival thickness 5. Thus, several authors have explored the use of biologic agents or growth 
factors, which are group of proteins capable to induce gene or cell activations for cell recruitment, 
matrix biosynthesis and cellular differentiation, in the attempt to regenerate the lost periodontium 
50, 6-10.  This review aims to present the mechanism of action, the rational and outcomes of biologics-
based regenerative technologies for the promotion of tooth root coverage. 
 
Enamel matrix derivative (EMD) 
Enamel matrix proteins are deposited on the developing tooth roots prior to the formation of the 
cementum 11, 12. It has been shown that EMD obtained from porcine fetal tooth EMD** 
biomimetically stimulates cementogenesis by enhancing proliferation and migration of periodontal 
ligament cells (PDL) and osteoblasts, mimicking the natural process of tooth development 13-15. While 
EMD has been initially proposed for periodontal regeneration, these proteins have also been 
investigated for root coverage procedures (Figure 1) and soft tissue healing 13 given its properties of 
enhancing vasculogenesis and local growth factor expression 13, 16, 17. However, whether or not EMD 
adds clinical benefits in the treatment of gingival recessions (GRs) remains unclear. Modica and 
coworkers demonstrated a greater mean root coverage and clinical attachment level (CAL) gain 
when EMD was used in combination with coronally advanced flap (CAF) when compared to CAF 
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alone 18. A multi-center study showed that the outcomes of root coverage procedure by using CAF + 
CTG can be further enhanced by the addition of EMD 6. However, other studies did not demonstrate 
a significant enhancement when using EMD in terms of greater root coverage results 7, 19-21, leading 
Del Pizzo et al. to conclude that the addition of EMD to CAF is not justified for clinical benefits of root 
coverage, but as an attempt to obtain periodontal regeneration 7. Indeed, an in-vivo histological 
study by McGuire & Cochran showed a site that received CAF + CTG healed with long-junctional 
epithelium and connective tissue attachment at the root surface, while new cementum, interspersed 
connective tissue (interpreted to be organizing periodontal ligament, PDL), and islands of condensing 
bone found at a fixed distance from the root surface was observed in the histological section of CAF 
+ EMD 8. The property of EMD to induce periodontal regeneration in GRs was later corroborated in a 
prospective case-control study involving a histological and micro-CT analysis by McGuire and co-
workers 22 (Figure 2). A recent randomized clinical trial evaluating the efficacy of several root 
coverage procedures (CAF alone, CAF + EMD, CAF + collagen matrix and CAF + collagen matrix + 
EMD) showed that CAF + collagen matrix + EMD was related to the greater percentage of complete 
root coverage 23. Similarly, other studies have suggested that combining allografts to EMD may 
enhance the clinical outcomes 24-26, probably due to the scaffold role of the graft material that 
contributes to the stability of the wound and maintains the space necessary for periodontal 
regeneration. In addition, the potential role of EMD in improving the esthetic results and patient 
satisfaction has been reported 27, 28. Lastly, it should be mention that the addition of biologics has 
been found to be beneficial in smokers 24, 26. 
 
Platelet-derived growth factor-BB (PDGF) 
Platelet-derived growth factor-BB (PDGF) is one of most investigated growth factors in periodontal 
tissue engineering. Since its early introduction in the late 1980s 29, several animal and clinical studies 
have confirmed its role in promoting bone, cementum and PDL regeneration 29-32. Regarding its 
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mechanism of action, it has been shown that PDL and alveolar bone cells express multiple receptors 
, , ,  for PDGF, which enhances proliferation and chemotaxis of these cells 30, 33-35. In particular, 
Boyan et al. investigated the effect of the various isoforms of recombinant human PDGF (AB, AA and 
BB) on the mitogenic and chemotactic responses of PDL cells, showing that PDGF-BB was the most 
potent one 36. McGuire & Scheyer were the first to investigate the use of rhPDGF-BB for the 
treatment of GRs in a case series involving the use of connective tissue graft (CTG) as controls9. After 
flap elevation, rhPDGF-BB solution was applied to the exposed root surfaces and to the coronal PDL 
fibers, and then a small amount of -tricalcium phosphate (-TCP) saturated with the rhPDGF-BB 
solution was placed over the root. A collagen matrix was saturated with the rhPDGF-BB solution and 
adapted over the graft before the suturing of the flap. The rationale of using -TCP as a carrier of the 
rhPDGF-BB†† is that -TCP particles have a scaffolding role preventing the soft tissue flap collapse 
against the root surface and providing a matrix for the new bone formation, facilitating also the 
stabilization of the blood clot. The treatment was found to be effective in terms of root coverage 
and esthetic outcomes, with no patients reporting adverse events. These findings led the authors to 
conclude that this case series provided proof-of-principle for the treatment of GRs with rhPDGF-BB 
plus -TCP and a collagen matrix without the need for autogenous CTG harvested from the palate 9.  
Based on these promising results, the same group designed a split-mouth randomized clinical trial 
comparing coronally advanced flap + rhPDGF-BB + -TCP + bioabsorbable collagen wound-healing 
dressing (test group) to CAF + CTG 10. Although the controls showed superior recession depth 
reduction after 9 months, the growth factor-treated sites displayed greater PD reduction at the 
study completion. Similar KTW gain, esthetic results and patient satisfaction was observed for both 
groups. In addition, the study included a histologic and micro-CT analysis of 6 treated teeth requiring 
extraction for orthodontic therapy. After 9 months, while CAF + CTG group showed healing with 
long-junctional epithelium and connective tissue fibers running parallel to the root surface, the 
growth factor-treated sites showed evidence of periodontal regeneration. Regenerated bone was 
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visualized coronal to the notch by micro-CT evaluation, while the histological analysis showed 
osteocytes and cementocytes entombed in newly formed bone and cementum. The newly 
regenerated PDL exhibited Sharpey fibers obliquely inserting into the newly formed cementum and 
bone. The study demonstrated that a correction of the GRs together with regeneration of the 
periodontium can be obtained using a PDGF-mediated approach 10 (Figure 3).  
Subsequent studies using rhPDGF-BB, combined to -TCP and collagen matrix 37 were compared to 
ADM 38 or to CTG 39 for root coverage applications. Deshpande and coworkers obtained a mean root 
coverage of 91.3% and 87.7% using CTG and rhPDGF-BB + -TCP + collagen membrane, respectively, 
while CAF alone achieved 68.6% of mean root coverage at 6 months 40.  
Although the use of rhPDGF-BB may achieve comparable outcomes with autologous CTG in the 
treatment of GRs, there is no evidence that a regenerated recession with new bone, cementum and 
PDL has a greater long-term stability than a recession treated with flap alone or CTG, which exhibit 
healing by repair. In a 5-year follow-up study, McGuire et al. showed good stability for 5 years as 
compared to the initial 6-month time point in terms of recession depth changes between CTG and 
rhPDGF-BB groups. However, CTG showed superior results in recession reduction, percentage of 
sites with complete root coverage and KTW gain 41.  
 
Platelet concentrates  
A patient’s own blood has been centrifugated in multiple fields of medicine to concentrate platelets 
in an attempt to increase the density of growth factors and potential enhance wound healing for soft 
and hard tissues.50 Platelet concentrates (PCs) have been considered as wound healing promoters 
for infrabony defects and sinus floor elevation 42, 43 as well as uses as a scaffold matrix in root 
coverage procedures 44, 45. Platelet-rich plasma (PRP) and plasma rich in growth factor (PRGF) are 
considered the first generation of PCs 46. Their impact on root coverage outcomes has been shown 
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to be minimal and in general, non-significant47-49. The biologic limitation of autogenous platelet 
concentrates is that the GF composition is orders of magnitude lower than can be achieved with 
recombinant GFs such as PDGFs and FGFs.  As such, it remains questionable that biologically relevant 
concentrations to promote significant regeneration can be achieved with these procedures 50.  
The second generation of PCs involves the centrifugation of the blood without the addition of 
anticoagulants 46. Based on the processing speed and duration, Platelet-rich fibrin (PRF) is classified 
in A-PRF, L-PRF and titanium prepared PRF (T-PRF). Among its advantages, the released of growth 
factors, including PDGF, vascular endothelial growth factors (VEGF), TGF -1 and Insulin-link growth 
factors (IGF-1), has been described 51, 52. In root coverage procedures, PRF has been investigated 
alone 45, in combination with tissue grafts 53 or as wound healing enhancer in the palatal donor site 
after harvesting procedures 54, 55. Nevertheless, it seems that the addition of PRF did not further 
enhance the outcomes of the root coverage procedure 53 and that autologous connective tissue graft 
remains the technique of choice 56, 57. A possible explanation is that gingival recessions benefit from 
the thickening of the soft tissue margin and PRF membranes do not act as scaffolds promoting the 
migration of cells from adjacent tissues. In addition, early studies demonstrated that higher 
concentration of factors typically expressed by platelets, such as IL-1 and TGF-, resulted in an 
inhibitory interaction on PDGF-AA by decreasing the number of PDGF- receptors and available 
binding sites, which may also explain the limited success of platelet concentrates for root coverage 
58, 59. In summary, the use of platelet concentrates containing insignificant enrichment of GF levels 
have failed to demonstrate significant enhancements in wound repair and root coverage. As such, 
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Fibroblast-growth factor-2 
Fibroblast growth factor-2 (FGF-2) is a heparin-biding cytokine which is able to enhance the 
angiogenic and osteogenic activity of multiple cellular populations 60-62. In addition, FGF-2 can 
stimulate the proliferation and migration of mesenchymal cells within the PDL 62. Given these strong 
wound healing characteristics, FGF-2 has been thoroughly explored in periodontal and bone 
regeneration, alone or in combination with scaffolding matrices 61, 63-65. Ishii and coworkers were the 
first to evaluate the effect of FGF-2 on root coverage outcomes in vivo 66. In a split-mouth 
randomized design, recession defects were created bilaterally and assigned to the treatment FGF-2 
alone or FGF-2 combined with a carrier matrix (-TCP). Microscopic and histometric analysis showed 
that both approaches were effective to inhibit epithelial down-growth while achieving some 
periodontal regeneration. In particular, FGF-2 + -TCP exhibited a greater amount of new bone and 
cementum formation than FGF-2 alone, suggesting that the GF benefits in combination with a 
scaffold that allows cellular and vascular invasion, migration and growth 66. When GR occurs, the 
facial alveolar bone is resorbed resulting in an unfavorable defect architecture for regeneration 61, 66, 
67. Therefore, it can be speculated that a scaffold provides better stability to the blood clot and GF. 
Consistent with these findings, two recent preclinical studies showed superior outcomes when FGF-2 
was incorporated into the scaffolds compared to FGF-2 alone 61, 68. Enhanced new cementum and 
bone was observed in the site treated with FGF-2 and a biodegradable sponge 61, while another 
group found that a collagen matrix scaffold was able to enhance the amount of root coverage of 
FGF-2 at 4 and 16 weeks 68. These preclinical studies showed that FGF-2, especially when 
incorporated into a scaffold enhances periodontal regeneration and root coverage. Nevertheless, 
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At this moment, biologic-based technologies have not yet been applied to implant dehiscence defect 
soft tissue coverage. 
 
Concluding remarks  
There is evidence supporting the use of EMD or PDGF for root coverage when the aim is to treat 
gingival recessions while correspondingly promoting periodontal regeneration. Platelet concentrates 
have demonstrated equivocal results and their clinical usage remains to be further determined. 
Preclinical data using FGF-2 are encouraging and human studies are required to determine the 
potential for clinical use. Future development of the use of biologics for soft tissue regeneration may 
involve coupling growth factors with next-generation bioresorbable scaffolds to augment both 
alveolar bone and soft tissue. 
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Figure Legend 
Figure 1. Root coverage procedure with connective tissue graft + EMD. A) Baseline defect; 
B) Split-full-split flap elevation; C) After root conditioning with 24% EDTA. EMD was 
applied to the root surface; D) CTG sutured over the EMD and the root surfaces; E) Flap 
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Figure 2. Clinical and histological efficacy of EMD in the regeneration of recession defects. A) Test 
gingival recession defect 8 weeks after the creation of the recession; B) Histologic marker being 
placed into root surface at the position of the free gingival margin after root planing and application 
of EDTA; C) Full-thickness flap creating recipient bed showing notch at the gingival margin level and 
relationship to the alveolar bone crest; D) Insertion of histologic notch into root surface at the level 
of the alveolar bone crest; E) Application of EMD over root surface; F) Healing at 9 months showing 
complete root coverage; G) Low-power ground section demonstrating both notches, newly formed 
bone (NB), and old and new cementum (OC and NC, respectively); H) Ground section showing new 
bone (NB) separated from old cementum (OC) by newly-formed periodontal ligament (PL); I) New 
bone (NB) covering previously exposed root surface. Root surface is covered by both old (OC) and 
new cementum (NC); J) Continuing down the root surface, new bone (NB), periodontal ligament (PL) 
and cementum (NC) can be seen covering the notch at the original gingival margin level; K) Section 
under polarized light showing newly formed periodontal ligament fibers (PL) between newly formed 
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Figure 3. Clinical and histological efficacy of rhPDGF-BB in the regeneration of recession 
defects. A) Clinical photograph of recession defect 2 months after its surgical creation. 
Osseous and gingival reference notches were placed at the time of surgical correction of the 
recession defect; B) In each case, the osseous crest was placed approximately 3 mm apical to 
the pre-corrected gingival margin; C) Complete root coverage is maintained 9 months after 
correction of the recession defect with rhPDGF-BB + -TCP; D) Nine months after grafting 
with rhPDGF-BB + -TCP, micro-CT reveals coronal bone regeneration superior to the 
osseous notch; E-G) Ground sections demonstrated robust coronal bone regeneration and 
newly formed cementum 9 months after grafting with rhPDGF-BB + -TCP; G) Higher-
power ground section revealing regeneration of all tissues of missing periodontium. (Adapted 
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Legend. SORT: Strength-of-Recommendation Taxonomy. SORT A: consistent, good-quality patient-oriented 
evidence; SORT B: inconsistent or limited-quality patient-oriented evidence; SORT-C: consensus, disease-
oriented evidence, usual practice, expert opinion or case series for studies of diagnosis, treatment, prevention, 
or screening 
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